A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model

Redmile Group

Sofinnova Partners

Home Biosciences

Today, we are extremely happy to announce the creation of our first venture, One Biosciences. Focused on generating precision medicines by leveraging the power of single-cell technologies, One Biosciences is backed and supported by Institut Curie and co-founded by Dr. Céline Vallot, a pioneer of single-cell data analysis globally. It is our first venture of a portfolio of high-potential and well-designed transformative technologies and assets that we will bring to key value inflexion points in an expedited and capital efficient manner, by leveraging strong operational guidance and drug development expertise as well as funding resources under one roof.
David Schilansky Magali RICHARD 
➡️ https://lnkd.in/e7T3J3h
➡️ https://lnkd.in/ehxN8Ma
#homebiosciences #institutcurie #biotech #medicalresearch #science

Very happy to be featured as one of the groundbreaking medical start-ups in Paris, Ile-de-France for 2024.

#innovation #biotech #france2030 

https://lnkd.in/dnWBSEb5

Interesting read on biotech funding !  


Thank you Willow Shah-Neville and Labiotech.eu for quoting us in your article !

https://lnkd.in/eV3mmKCY

Merci au magazine Pharmaceutiques pour ce très bel article sur l'écosystème de la valorisation de l'innovation et de la recherche en santé. 

Home Biosciences, première société de biotechnologie dédiée au venture building en Europe Continentale est fière de s'inscrire dans cette démarche capitale pour l'innovation en France !

Merci à Juliette Badina✏️et Julie Wierzbicki pour le temps consacré à Home Biosciences dans la rédaction de cet article très riche.

Merci à nos actionnaires pour leur soutien constant qui s'inscrit pleinement dans le plan France2030eu:
Redmile Group, Sofinnova Partners

Merci à notre équipe qui permet de transformer ces brillantes innovations en solutions concrètes et nouvelles thérapies pour les patients 
Nicolas Doulet, Guillaume Hagege, ROMAIN LETOURNEUR, Magali RICHARD, David Schilansky, Reine Wang

https://lnkd.in/eBP2h-e


Neuroute focuses on streamlining clinical development through artificial intelligence.

Neuroute

One Biosciences leverages single-cell analysis and AI to unlock precision medicines for difficult-to-treat diseases.

One Biosciences

Home Biosciences is a biotech company dedicated to unlocking scientific breakthroughs by leveraging an asset-centric operating model. They are focused on generating precision medicines by leveraging the power of single-cell technologies.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 4, 2024 2:30 AM	b463e85f
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 4, 2024 2:30 AM	78fce0b5
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 4, 2024 2:30 AM	7f58f9b6
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 4, 2024 2:30 AM	f4579ef3
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:HOMEBIOSCIENCES

Home Biosciences